Epidemic and Endemic Spread of Klebsiella pneumoniae Producing SHV-5 Beta-Lactamase in Dubrava University Hospital, Zagreb, Croatia

References

• Philippon A, Labia R, Jacoby G. Extended-spectrum 13-lactamases. Antimicrob Agents Chemother 1989; 33 (8): 1131–6.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Medeiros AA. More extended-spectrum 13-lactamases. Antimicrob Agents Chemother 1991; 35 (9): 1697–1704.
   PubMed Web of Science ®Google Scholar
• Bedenié B, Žagar Ž. Extended-spectrum I3-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 1998; 10 (6): 449–59.
   PubMed Web of Science ®Google Scholar
• Bedenié B, Randegger CC, Stobberingh E, Haechler H. Molecular epidemiology of extended-spectrum I3-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis 2001; 20 (7): 505–8.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard. NCCLS document M100-59, Vol. 19, No 1. Villanova, PA: NCCLS, 1999.
   Google Scholar
• National Committee for Clinical Laboratory standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically; Approved standard. 5th ed. NCCLS document M7-A5, Wayne, Pennsylvania: NCCLS, 2000: 1-25.
   Google Scholar
• Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V Ed. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore MD: Williams & Wilkins, 1986: 683–721.
   Google Scholar
• Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum I3-lactamases conferring transferable resistance to newer I3-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10 (4): 867–78.
   PubMedGoogle Scholar
• Matthew MA, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of 13-lactamases. J Gen Microbiol 1975; 88: 169–178.
   PubMedGoogle Scholar
• Labia R, Guionie M: Semi-quantification of a microbio-logical method using I3-lactamases in detecting the hydrolysis of I3-lactam antibiotics. Ann Microbiol 1981; 132B(2): 257–65.
   Google Scholar
• Ntiesch-Inderbinen MT, Hachler H, Kayser FH. Detection of genes coding for extended-spectrum SHV I3-lacta-mases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996; 15 (5): 398–402.
   PubMed Web of Science ®Google Scholar
• Hall TA. Bio Edit: a user-friendly biological for sequence alignments and analysis program for Windows 95/98 NT. Nucleic Acids Symp Ser 2004; 41: 95–8.
   Google Scholar
• Birnboim HC, Doly J. A rapid alkaline extraction proce-dure for screening recombinant plasmid DNA. Nucleic acid research 1979; 7 (6): 1513–23.
   PubMed Web of Science ®Google Scholar
• Kaufman ME. Pulsed-Field Gel Electrophoresis. In: Woodfor N, Johnsons A, eds. Molecular bacteriology. Protocols and clinical applications. New York; Humana Press Inc. Totowa, 1998: 33-51.
   Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interprinting chromosomal DNA restriction patterns produced by pulsed-filed gel electrophoresis; criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233–9.
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 I3-lactamase among hospitalized patients. Infection 1993; 21 (1): 18–22.
   PubMed Web of Science ®Google Scholar
• Prodinger WM, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 13-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34 (3): 564–8.
   PubMed Web of Science ®Google Scholar
• Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5 type extended-spectrum I3-lactamases. Antimicrob Agents Chemother 1998; 42 (3): 514–520.
   PubMed Web of Science ®Google Scholar
• Marchese A, Arlet G, Schito GC, Langrange PH, Philippon A. Detection of SHV-5 I3-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis 1996; 15 (3): 245–8.
   PubMed Web of Science ®Google Scholar
• Gutmann L, Ferre B, Goldstein FW, et al. SHV-5 a novel SHV-type 13-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989; 33 (6): 951–6.
   PubMed Web of Science ®Google Scholar
• French GL, Shannon KP, Simmons N. Hospital out-break of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and 13-lactam-I3-lactamase inhibitor combina-tions by hyperproduction of SHV-5 I3-lactamase. J Clin Microbiol 1996; 34 (2): 358–63.
   PubMed Web of Science ®Google Scholar
• Vatopoulos AC, Philip pon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type I3-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26 (5): 63548.
   Google Scholar
• Pragai Z, Koczian Z, Nagy E. Characterization of the extended-spectrum I3-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary. J Antimicrob Chemother 1998; 42 (3): 401–3.
   PubMed Web of Science ®Google Scholar
• Mulgrave L, Attwood PV. Characterization of an SHV-5 related extended-spectrum I3-lactamase in Enterobacteriaceae from Western Australia. Pathology 1993; 25 (1): 71–5.
   PubMed Web of Science ®Google Scholar
• Mulvey MR, Bryce B, Boyd D, et al. Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. Ambler class A extend-ed-spectrum P-lactamase-producing Escherichia coli and Klebsiella spp in Canadian hospitals. Antimicrob Agents Chemother 2004; 48 (4): 1204-14.
   Google Scholar
• Miranda G, Castro N, Lcanos B, et al. Clonal and hori-zontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum I3-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004; 42 (1): 30–35.
   PubMed Web of Science ®Google Scholar
• Chanawong A, M'Zali F, Heritage J, Lulitanond A, Hawkey PM. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum I3-lactamases in Gram-negative bacteria isolated in a University Hospital in Thailand. J Antimicrob Chemother 2001; 48 (6): 839–52.
   PubMed Web of Science ®Google Scholar
• Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum I3-lactamases (ESBLs). Clin Microbiol Infect 2000; 6 (9): 460–3.
   PubMed Web of Science ®Google Scholar
• Essack SY. Treatment options for extended-spectrum 13-lactamase-producers. FEMS Microbiol Lett 2000; 190 (2): 181–4.
   PubMed Web of Science ®Google Scholar
• Amyes SBG. Miles RS. Extended-spectrum I3-lacta-mases: the role of inhibitors in therapy. J Antimicrob Chemother 1998; 42 (4): 415–7.
   PubMed Web of Science ®Google Scholar
• Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediat-ed AmpC I3-lactamase and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41 (3): 563–9.
   PubMed Web of Science ®Google Scholar
• MacKenzie FM, Forbes KJ, Dorai-John TM, Amyes SG. Emergence of carbapenem-resistant Klebsiella pneumoniae. Lancet 1997; 13, 350 (9080): 783.
   Google Scholar